Comparison of schizophrenia outpatients in residential care facilities with those living with someone: Study of mental and physical health, cognitive functioning, and biomarkers of aging

scientific article published on 27 February 2019

Comparison of schizophrenia outpatients in residential care facilities with those living with someone: Study of mental and physical health, cognitive functioning, and biomarkers of aging is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.PSYCHRES.2019.02.067
P932PMC publication ID6504557
P698PubMed publication ID30925304

P50authorDilip V. JesteQ5276818
A'verria Sirkin MartinQ114440883
P2093author name stringDilip V Jeste
Jinyuan Liu
Colin A Depp
Christopher N Kaufmann
Xin M Tu
Ellen E Lee
Rebecca E Daly
Julie Kangas
P2860cites workInfluence of psycho-social factors on the emergence of depression and suicidal risk in patients with schizophrenia.Q47585550
Housing model for persons with serious mental illness moderates the relation between loneliness and quality of lifeQ47623368
Reliability and validity of Quality of Life assessed by the Short-Form 36 and the Modular System for Quality of Life in patients with schizophrenia and patients with depressionQ47760837
Negative v positive schizophrenia. Definition and validationQ48923421
Assessing the New York City involuntary outpatient commitment pilot program.Q51069144
Can involuntary outpatient commitment reduce hospital recidivism?: Findings from a randomized trial with severely mentally ill individuals.Q51084238
Systemic Biomarkers of Accelerated Aging in Schizophrenia: A Critical Review and Future Directions.Q51768375
Older patients with schizophrenia: nature of dwelling status and symptom severity.Q51950766
The MOS 36-Item Short Form Health Survey: reliability, validity, and preliminary findings in schizophrenic outpatients.Q51994276
Mental illness and family burden: a public health perspective.Q52098258
Death and deinstitutionalization.Q52102232
A depression rating scale for schizophrenicsQ68663014
A Systematic Review of Mortality in SchizophreniaQ22253025
Supported housing for people with severe mental disordersQ24244345
Pragmatic replication trial of health promotion coaching for obesity in serious mental illness and maintenance of outcomesQ24288983
The MOS 36-ltem Short-Form Health Survey (SF-36)Q26778425
Community treatment orders for patients with psychosis (OCTET): a randomised controlled trialQ28287933
A global measure of perceived stressQ29547166
A behavioral weight-loss intervention in persons with serious mental illnessQ30542864
Cumulative illness rating scaleQ34237005
Distinguishing optimism from neuroticism (and trait anxiety, self-mastery, and self-esteem): a reevaluation of the Life Orientation TestQ34315511
Best practices: Optimizing care for people with serious mental illness and comorbid diabetesQ35835732
Peer-led healthy lifestyle program in supportive housing: study protocol for a randomized controlled trialQ36019597
Associations of high sensitivity C-reactive protein levels in schizophrenia and comparison groupsQ36113651
A Randomized Trial Examining Housing First in Congregate and Scattered Site FormatsQ36246201
Is schizophrenia a syndrome of accelerated aging?Q37044422
Wellness within illness: happiness in schizophreniaQ37055624
Usefulness of the UCSD performance-based skills assessment (UPSA) for predicting residential independence in patients with chronic schizophreniaQ37227379
Development of a brief scale of everyday functioning in persons with serious mental illness.Q37427135
Deinstitutionalization? Where have all the people gone?Q38004949
Use of Clinical Markers to Identify Metabolic Syndrome in Antipsychotic-Treated PatientsQ38497882
New perspectives on schizophrenia in later life: implications for treatment, policy, and researchQ38584812
Accelerated aging in schizophrenia and related disorders: Future researchQ38660762
Variable selection for distribution-free models for longitudinal zero-inflated count responses.Q38942179
Abnormalities in chemokine levels in schizophrenia and their clinical correlatesQ39075961
Inflammation in Schizophrenia: Cytokine Levels and Their Relationships to Demographic and Clinical VariablesQ39166258
Development of a new resilience scale: the Connor-Davidson Resilience Scale (CD-RISC).Q39266372
Psychometric analysis and refinement of the Connor-davidson Resilience Scale (CD-RISC): Validation of a 10-item measure of resilienceQ39274466
Loneliness and related factors among people with schizophrenia in Japan: a cross-sectional study.Q39530925
Tenant outcomes in supported housing and community residences in New York CityQ39760979
Inconsistency Between Univariate and Multiple Logistic RegressionsQ41066595
Health-Seeking Behavior and Social Networks of the Aged Living in Single-Room Occupancy HotelsQ41632062
SF-36 scales, and simple sums of scales, were reliable quality-of-life summaries for patients with schizophrenia.Q45619576
A widening longevity gap between people with schizophrenia and general population: A literature review and call for actionQ46224220
The problem: How many patients live in residential care facilities?Q46552971
A comparison of community-dwelling older schizophrenia patients by residential statusQ46591440
Assisted living and use of health services among medicaid beneficiaries with schizophreniaQ46695208
Loneliness in schizophrenia and its possible correlates. An exploratory studyQ47386445
Schizophrenia and aging: no more dearth of data?Q47393373
P921main subjectschizophreniaQ41112
biomarkerQ864574
P304page(s)162-168
P577publication date2019-02-27
P1433published inPsychiatry ResearchQ15750888
P1476titleComparison of schizophrenia outpatients in residential care facilities with those living with someone: Study of mental and physical health, cognitive functioning, and biomarkers of aging
P478volume275

Search more.